Newer long-term treatments for multiple sclerosis. [electronic resource]
- Clinical neurology and neurosurgery Jul 2002
- 265-71 p. digital
Publication Type: Journal Article; Review
0303-8467
10.1016/s0303-8467(02)00050-1 doi
Adjuvants, Immunologic--therapeutic use Adrenal Cortex Hormones--therapeutic use Antibody Formation Combined Modality Therapy Cost-Benefit Analysis Disease Progression Ethics, Medical Glatiramer Acetate Health Care Costs Humans Immunoglobulins, Intravenous--therapeutic use Immunosuppressive Agents--therapeutic use Interferon beta-1a Interferon beta-1b Interferon-beta--therapeutic use Multiple Sclerosis--complications Peptides--therapeutic use Plasmapheresis Prognosis Quality of Life Recurrence